530881 — Arunjyoti Bio Ventures Income Statement
0.000.00%
Last trade - 00:00
- IN₹100.50m
- IN₹515.30m
- IN₹18.30m
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 37.2 | 73.1 | 55.1 | 32.5 | 18.3 |
Cost of Revenue | |||||
Gross Profit | 5.77 | 12.2 | 7.01 | 3.69 | 3.35 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.8 | 71.8 | 54.2 | 31.7 | 15.6 |
Operating Profit | 0.44 | 1.31 | 0.938 | 0.77 | 2.66 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.438 | 1.31 | 0.922 | 0.76 | 2.66 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.438 | 1.06 | 0.683 | 0.563 | 2.22 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.438 | 1.06 | 0.683 | 0.563 | 2.22 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.438 | 1.06 | 0.683 | 0.563 | 2.22 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.039 | 0.094 | 0.06 | 0.05 | 0.196 |